Amgen reported $1.38B in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.07B 228M
Acceleron Pharma XLRN:US $ 35.47M 4.41M
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
ALKERMES ALKS:US 139.19M 14.02M
Amgen AMGN:US $ 1.38B 130M
Astrazeneca AZN:US 2.57B 76M
Biogen BIIB:US $ 637.3M 42.3M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Coherus Biosciences CHRS:US $ 40.34M 954K
Dicerna Pharmaceuticals DRNA:US $ 25.46M 4.79M
Eli Lilly And LLY:US $ 1.69B 109.7M
Exelixis EXEL:US $ 98.49M 3.86M
Genmab GEN:DC 264M 63M
Gilead Sciences GILD:US $ 1.34B 297M
Glaxosmithkline GSK:US 2.5B 183M
GlaxoSmithKline GSK:LN 2.5B 183M
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
IONIS PHARMACEUT IONS:US $ 56.46M 4.74M
Johnson & Johnson JNJ:US $ 6.07B 641M
Merk MRK:US $ 2.25B 376M
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Moderna Inc MRNA:US 121M 44M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Novartis NOVN:VX 3.71B 190M
Novartis NVS:US 3.71B 190M
Pfizer PFE:US $ 2.79B 134M
Ptc Therapeutics PTCT:US $ 68.88M 7.78M
Puma Biotechnology PBYI:US $ 39.41M 11.17M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Seattle Genetics SGEN:US $ 165.13M 5.29M
Takeda 4502:JP 219.84B 14.55B
Teva Pharmaceutical TEVA:IT 832M 16M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
YTE INCY:US $ 168.86M 15.06M